Day: September 18, 2025

Payments were received Aug. 27, 2025, and Sept. 12, 2025, respectively, from Pritchard Automotive for DB Schenker and Ziegler Truck Group for previously announced Sept. 4, 2025, sale of vehicles Combined with previously announced expense reductions, Company moves closer to cashflow breakeven BREA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — via IBN – Bollinger Innovations, Inc. (NASDAQ: BINI) (“Bollinger Innovations” or the “Company”), an electric vehicle (“EV”) manufacturer, today announces it has received $1,074,035 for vehicles sold in August 2025. Payments were received Aug. 27, 2025 and Sept. 12, 2025, respectively from Pritchard Automotive for DB Schenker and Ziegler Truck Group for the previously announced sale of Class 1, 3 and 4 commercial electric vehicles on Sept. 4, 2025. “The sale to Ziegler Truck Group is an important...

Wugen closed a $115 million equity financing led by Fidelity Management & Research Company HCW Biologics holds a minority equity interest in Wugen MIRAMAR, Fla., Sept. 18, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, congratulates Wugen, Inc. (“Wugen”) on its recently announced $115 million equity financing led by Fidelity Management & Research Company, with participation from RiverVest Venture Partners, Lightchain Capital, Abingworth, ICG, LYZZ Capital, Tybourne Capital Management, Aisling Capital Management, and other leading life sciences investors. HCW Biologics...

$6 million upfront with up to an additional $6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA] (“BioCardia” or the “Company”), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the pricing of a public offering of an aggregate of 4,800,000 shares of its common stock and short-term warrants to purchase up to 4,800,000 shares of common stock, at a combined public offering price of $1.25 per share and accompanying short-term warrant. The short-term warrants will have an exercise price of $1.25 per share, will be exercisable upon issuance and will expire two years thereafter. The closing of the offering is expected to occur on...

WOBURN, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) on September 16th to discuss the complete response letter (CRL) for the Company’s Biologics License Application (BLA) for RP1 in combination with nivolumab for the treatment of advanced melanoma. The company is evaluating the feedback from the FDA provided during the meeting to determine next steps. At this time, a path forward under the accelerated approval pathway has not been determined. “The feedback from the melanoma community, including patients and physicians, clearly highlights the unmet need in advanced melanoma and the compelling...

Company to Seek Shareholder Approval for New Director Appointments SCOTTSDALE, AZ, Sept. 18, 2025 (GLOBE NEWSWIRE) — Following its announcement yesterday regarding a strategic refresh of its Board of Directors, Safety Shot, Inc. (Nasdaq: SHOT) is providing further details on the implementation of these changes. The appointment of the three new directors, as well as the resignations of Jordan Schur and Rich Pascucci, will not be effective until the Company achieves shareholder approval which is anticipated to take place in October. In addition, as the Company previously announced, it has reserved the trading symbol “BNKK” with Nasdaq as part of its forward-looking strategy. The Company will formally implement a name change and new symbol in the near term. “The shareholder vote is a positive and required step in formally completing...

Investor Presentation to be held at 1:15 p.m. Eastern Time BOHEMIA, N.Y., Sept. 18, 2025 (GLOBE NEWSWIRE) — Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025. Company WebcastThe webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2025/ or directly at https://app.webinar.net/p9KWyQokRGL. The webcast will also be available for replay following the event. 1×1 MeetingsManagement will be participating...

NEWARK, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced the launch of its Agentic Operating Framework, optimized to help enterprises overcome the common problems behind the widespread AI pilot failures in businesses today. Building on decades of expertise earned by helping the world’s best brands create differentiated customer experiences, the Agentic Operating Framework combines cutting-edge technologies with deep consulting capabilities to move AI from failed pilots to real operational impact. The Framework delivers a full ecosystem of agentic AI services—from readiness and strategy to brand-aligned language models, agentic engineering, data management, and monitoring— integrating Concentrix’ technology-agnostic approach with strategic partners...

FALLS CHURCH, Va., Sept. 18, 2025 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) announced today that its third quarter 2025 financial results will be released on Tuesday, October 21, 2025, prior to the market opening. The earnings announcement, and accompanying earnings presentation, will be available on the company’s website at http://investor.northropgrumman.com. Earnings Call Webcast The company will host a live, audio only, earnings call webcast at 9:30 a.m. ET the same day. This webcast can be accessed on the company’s website at http://investor.northropgrumman.com. A replay of the webcast will be available shortly after the call and will remain available for a limited time. About Northrop GrummanNorthrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our...

We hereby inform that, by the decision of the Supervisory Council of AB „KN Energies“ (hereinafter – the Company), as of 17 September 2025 and until the end of term of office of Company’s acting Supervisory Council, Aurimas Salapėta was elected as a member of the Company’s Remuneration and Nomination Committee. He will be joining current members Živilė Valeišienė and Robertas Vyšniauskas. The Remuneration and Nomination Committee consists of 3 (three) members, 1 (one) of which is independent, and 2 (two) are designated members of the Supervisory Council. Chief Corporate Affairs Officer Jurgita Šilinskaitė-Venslovienė+370 46 391772

SAN DIEGO, Sept. 18, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that advisors, Benjamin Worley, AAMS®, and Robert Monroe, CFP®, have come together to form Worley Monroe Advisors and join LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. They reported serving approximately $400 million in advisory, brokerage and retirement plan assets* and join LPL from Edward Jones. Based in southeast Missouri in the town of Dexter, the team has 36 years of experience. Worley’s interest in finance was sparked at a young age when he began investing in the stock market. He continued to invest throughout his teenage years before pursuing the career professionally. Monroe has always enjoyed working with people and served as a worship pastor for 16 years before joining the financial services sector....